# Edward-Elmhurst Health

> Edward-Elmhurst Health is a VC fund backing Health Care and Medical Device. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Naperville, United States
- Total investments: 10
- Last investment: Apr 2023
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/edward-elmhurst-health/
- X (Twitter): https://www.twitter.com/healthydriven
- Website: https://www.eehealth.org
- Facebook: https://www.facebook.com/healthydriven

Edward-Elmhurst Health is an integrated health system comprised of three hospitals.

## Contacts

5 contacts available for Edward-Elmhurst Health. Shizune tracks 2 team members at Edward-Elmhurst Health. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/edward-elmhurst-health?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 70% |
| Medical Device | 4 | 40% |
| Biotechnology | 2 | 20% |
| Medical | 1 | 10% |
| Hospital | 1 | 10% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 40% |
| Funding Round | 3 | 30% |
| Pre-Seed | 1 | 10% |
| Series B | 1 | 10% |
| Venture - Series Unknown | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bill Kottmann | CEO | 0 | — |
| John Lee | CMIO | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Memora Health | Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $30M |  | Apr 18, 2023 |  |
| Digital Diagnostics | Digital Diagnostics, formerly IDx, is a pioneering AI diagnostics company founded with a mission to transform the quality, accessibility, equity, and affordability of healthcare worldwide through the application of technology in the medical diagnosis and treatment process. Founded by Michael Abramoff, MD, PhD, a fellowship-trained retinaspecialist, neuroscientist, and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build an autonomous AI platform that makes clinical decisions without human intervention, removing the diagnostic burden of common diseases from specialists. Digital Diagnostics is paving the way for autonomous AI diagnosis to become the new standard of care, helping to democratize healthcare and close care gaps to improve patient outcomes. By working closely with patient advocacy groups, federal regulators, and other quality of care and ethics-focused stakeholders, Digital Diagnostics is working with the healthcare system to enable the continued adoption of autonomous AI. | $75M | Series B | Aug 23, 2022 |  |
| NovaXS Biotech | NovaXS is developing the next generation of smart needle-free drug delivery platform that improves the medication adherence and optimizes the treatment outcomes. | $1.5M | Seed | Mar 15, 2022 |  |
| NXgenPort | NXgenPort Inc is addressing an unmet need in cancer care by remotely monitoring patients between chemotherapy visits with an implanted Smart Port. By measuring cell counts and heart function in vivo, NGP will alert physicians to signs of infection, reduce hospitalizations, and gather important physiological data to improve patient outcomes. Thereis additional value for cancer researchers and drug delivery stakeholders to remotely monitor a participant's biological response to interventions. |  | Pre-Seed | Mar 01, 2022 |  |
| Memora Health | Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $40M | Venture - Series Unknown | Feb 15, 2022 |  |
| Walela | Walela is a medical device company that develops sensor technology to improve fetal and maternal outcomes. It measures fetal heart rate and blood pH using its specialized medical technology. The company was founded by James Balman in 2021 and is headquartered in Chicago, Illinois. | $237.5K | Seed | Nov 21, 2021 |  |
| Ready, Set, Food! | Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system. | $3.5M |  | Jun 03, 2021 |  |
| Ready, Set, Food! | Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system. | $3.5M | Seed | Jun 03, 2021 |  |
| Memora Health | Memora Health, the leading intelligent care enablement platform, helps clinicians focus on top-of-license practice while proactively engaging patients along complex care journeys. Memora partners with leading health systems, health plans, and digital health companies to transform the care delivery process for care teams and patients. Our platformdigitizes and automates high-touch clinical workflows, supercharging care teams by intelligently triaging patient-reported concerns and data to appropriate care team members and providing patients with proactive, two-way communication and support. Memora Health is headquartered in San Francisco, CA, with clients and team members around the country, and is backed by Andreessen Horowitz, Transformation Capital, General Catalyst, AlleyCorp, Frist Cressey Ventures, Martin Ventures, Kevin Durant and Rich Kleiman's Thirty Five Ventures, and several other strategic healthcare groups.To learn more about Memora’s vision to make care more actionable, accessible and always-on, visit memorahealth.com. | $10.5M | Seed | May 11, 2021 |  |
| Smart Choice MRI | Smart Choice MRI, LLC provides high-quality magnetic resonance imaging services for a fair, transparent price of $600 or less. All scans are preformed using advanced GE technology and are read by board certified, sub-specialized radiologists at the Cleveland Clinic. Founded in 2006, it currently has locations across Illinois and Wisconsin. | $7M |  | May 16, 2016 |  |

10 of 10 investments shown.

## Co-investors
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 2 deals together
- [Baxter International](https://shizune.co/investors/profile/baxter-international) — VC Fund, 2 deals together
- [Danone Manifesto Venture](https://shizune.co/investors/profile/danone-manifesto-venture) — VC Fund, 2 deals together
- [Frist Cressey Ventures](https://shizune.co/investors/profile/frist-cresseyventures) — VC Fund, 2 deals together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 2 deals together
- [mHUB](https://shizune.co/investors/profile/mhub-3) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Edward-Elmhurst Health invest in?

Edward-Elmhurst Health invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Edward-Elmhurst Health?

Public channels for Edward-Elmhurst Health include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Edward-Elmhurst Health?

The team at Edward-Elmhurst Health includes Bill Kottmann (CEO) and John Lee (CMIO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co